Ovarian Cancer | Specialty

The OncLive Ovarian Cancer condition center page is a comprehensive resource for clinical news and expert insights on ovarian cancer and evolving treatment approaches, including PARP inhibitors, antibody-drug conjugates, chemotherapy and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in ovarian cancer.

Ongoing PARP Trials in Recurrent Ovarian Cancer

July 27th 2018

Recurrent Ovarian Cancer: PARP Inhibitors Compared

July 27th 2018

Using Maintenance Therapy in Recurrent Ovarian Cancer

July 27th 2018

PARP Maintenance Therapy in Recurrent Ovarian Cancer

July 27th 2018

A New Standard of Care in Recurrent Ovarian Cancer?

July 27th 2018

The GOG-0213 Trial in Recurrent Ovarian Cancer

July 27th 2018

Using Novel Therapies in Advanced Ovarian Cancer

July 27th 2018

Advanced Ovarian Cancer: Emerging Therapies

July 27th 2018

Targeting VEGF in Advanced Ovarian Cancer

July 27th 2018

Neoadjuvant Therapy in Advanced Ovarian Cancer

July 27th 2018

Surgical Controversies in Advanced Ovarian Cancer

July 27th 2018

Molecular Testing in Ovarian Cancer

July 27th 2018

Chemotherapy in Early-Stage Ovarian Cancer

July 27th 2018

Surgery in Early-Stage Ovarian Cancer

July 27th 2018

Dr. Konstantinopoulos on Rationale for TOPACIO Trial in Ovarian Cancer

July 25th 2018

Panagiotis A. Konstantinopoulos, MD, PhD, director, Translational Research, Gynecologic Oncology, Dana-Farber Cancer Institute, associate professor of medicine, Harvard Medical School, discusses the rationale behind the TOPACIO trial for the treatment of patients with recurrent ovarian cancer.

Dr. Matulonis Discusses Rationale of QUADRA Trial

July 24th 2018

Ursula A. Matulonis, MD, chief, Division of Gynecological Oncology, Dana-Farber Cancer Institute, professor of medicine, Harvard Medical School, discusses the rationale behind the QUADRA trial for patients with relapsed ovarian cancer.

Dr. Markman on Latest Advances in Treatment of Gynecological Malignancies

July 18th 2018

Maurie Markman, MD, president of Medicine and Science, Cancer Treatment Centers of America, discusses the latest advances in treatment for gynecological malignancies and other tumor types.

Dr. Hardesty on Second-Line Maintenance Therapy for Ovarian Cancer

July 17th 2018

Melissa Hardesty, MD, gynecologic oncologist, Alaska Women’s Cancer Center, discusses second-line maintenance therapy after frontline chemotherapy for patients with ovarian cancer.

Dr. Konecny on Resistance to PARP Inhibitors in Ovarian Cancer

July 17th 2018

Gottfried E. Konecny, MD, associate professor of medicine, University of California, Los Angeles, discusses resistance to PARP inhibitors in ovarian cancer.

Dr. Pietras Discusses Pain Management in Ovarian Cancer

July 13th 2018

Christopher J. Pietras, MD, director, Palliative Care, assistant clinical professor, University of California, Los Angeles (UCLA) School of Medicine, discusses pain management in patients with ovarian cancer.